Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

Summary

This proposed study aims to evaluate the efficacy of a daily oral cannabinoid oil preparation in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the relationship between inflammation, anxiety and cannabinoids using biological markers as well as examine the neuro-cognitive effects of cannabinoid treatment.

Timeline

Start

2021-04

Primary completion

2023-04

Completion

2023-06

Outcome

Outcome not reported

Stopped (Enrollment): “Project cancelled prior to commencing recruitment”

Drugs

Indications